Open?label phase II clinical trial of orteronel (TAK?700) in metastatic or advanced non?resectable granulosa cell ovarian tumors: the Greko II study (GETHI2013?01) - Jesús García Donas; Laia Garrigós; Nuria Láinez Milagro; Ana Santaballa Bertrán; A Redondo Sánchez; Juan Fernando Cueva Bañuelos; María Jesús Rubio Pérez; Mario Prieto; José Antonio López Guerrero; Zaida Garcia Casado; Aranzanzu Barquin; Enrique Grande Pulido; et al. (Clinical & Translational Oncology, 2025)